These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 23049545)
21. Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease. Xia HH; Phung N; Kalantar JS; Talley NJ Med J Aust; 2000 Nov; 173(10):515-9. PubMed ID: 11194733 [TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori-negative duodenal and pyloric ulcer: role of NSAIDs. Hyvärinen H; Salmenkylä S; Sipponen P Digestion; 1996; 57(5):305-9. PubMed ID: 8886573 [TBL] [Abstract][Full Text] [Related]
23. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use. al-Assi MT; Genta RM; Karttunen TJ; Graham DY Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738 [TBL] [Abstract][Full Text] [Related]
24. Interaction of Helicobacter pylori (Hp) and nonsteroidal anti-inflammatory drugs (NSAID) on gastric mucosa and risk of ulcerations. Konturek PC; Konturek SJ; Cześnikiewicz M; Płonka M; Bielański W Med Sci Monit; 2002 Sep; 8(9):RA197-209. PubMed ID: 12218957 [TBL] [Abstract][Full Text] [Related]
25. Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan. Chen TS; Luo JC; Chang FY J Gastroenterol Hepatol; 2010 May; 25(5):919-22. PubMed ID: 20074147 [TBL] [Abstract][Full Text] [Related]
26. What consideration should be given to Helicobacter pylori in treating nonsteroidal anti-inflammatory drug ulcers? Hawkey CJ Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S17-20. PubMed ID: 10929894 [TBL] [Abstract][Full Text] [Related]
27. Clinical and endoscopic characteristics of non-Helicobacter pylori, non-NSAID duodenal ulcers: a long-term prospective study. Xia HH; Wong BC; Wong KW; Wong SY; Wong WM; Lai KC; Hu WH; Chan CK; Lam SK Aliment Pharmacol Ther; 2001 Dec; 15(12):1875-82. PubMed ID: 11736717 [TBL] [Abstract][Full Text] [Related]
28. Helicobacter pylori and duodenal ulcer. A study of duodenal ulcer patients and their first-degree relatives. Valle J; Pikkarainen P; Vuoristo M; Sipponen P; Kekki M; Siurala M Scand J Gastroenterol Suppl; 1991; 186():45-51. PubMed ID: 1759128 [TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori negative, non-steroidal anti-inflammatory drug-negative peptic ulcers in India. Goenka MK; Majumder S; Sethy PK; Chakraborty M Indian J Gastroenterol; 2011 Feb; 30(1):33-7. PubMed ID: 21424697 [TBL] [Abstract][Full Text] [Related]
31. Relationship between non-steroidal anti-inflammatory drug use and Helicobacter pylori infection in bleeding or uncomplicated peptic ulcers: A case-control study. Okan A; Tankurt E; Aslan BU; Akpinar H; Simsek I; Gonen O J Gastroenterol Hepatol; 2003 Jan; 18(1):18-25. PubMed ID: 12519219 [TBL] [Abstract][Full Text] [Related]
32. The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010. Musumba C; Jorgensen A; Sutton L; Van Eker D; Moorcroft J; Hopkins M; Pritchard DM; Pirmohamed M Aliment Pharmacol Ther; 2012 Jul; 36(1):48-56. PubMed ID: 22554233 [TBL] [Abstract][Full Text] [Related]
33. Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users. Sostres C; Carrera-Lasfuentes P; Benito R; Roncales P; Arruebo M; Arroyo MT; Bujanda L; García-Rodríguez LA; Lanas A Am J Gastroenterol; 2015 May; 110(5):684-9. PubMed ID: 25895518 [TBL] [Abstract][Full Text] [Related]
35. Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcers. Konturek SJ; Bielański W; Płonka M; Pawlik T; Pepera J; Konturek PC; Czarnecki J; Penar A; Jedrychowski W Scand J Gastroenterol; 2003 Sep; 38(9):923-30. PubMed ID: 14531527 [TBL] [Abstract][Full Text] [Related]
36. Genotypes of Helicobacter pylori obtained from gastric ulcer patients taking or not taking NSAIDs. Li L; Kelly LK; Ayub K; Graham DY; Go MF Am J Gastroenterol; 1999 Jun; 94(6):1502-7. PubMed ID: 10364014 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of non-Helicobacter pylori duodenal ulcer in Karachi, Pakistan. Yakoob J; Jafri W; Jafri N; Islam M; Abid S; Hamid S; AliShah H; Shaikh H World J Gastroenterol; 2005 Jun; 11(23):3562-5. PubMed ID: 15962375 [TBL] [Abstract][Full Text] [Related]
38. Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population. Nishikawa K; Sugiyama T; Kato M; Ishizuka J; Komatsu Y; Kagaya H; Katagiri M; Nishikawa S; Hokari K; Takeda H; Asaka M Eur J Gastroenterol Hepatol; 2000 Jun; 12(6):635-40. PubMed ID: 10912481 [TBL] [Abstract][Full Text] [Related]
39. [What role today for Helicobacter pylori in peptic ulcer?]. Cadiot G Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):409-14. PubMed ID: 12700497 [TBL] [Abstract][Full Text] [Related]
40. Serum and gastric luminal epidermal growth factor in Helicobacter pylori-associated gastritis and peptic ulcer disease. Lynch DA; Mapstone NP; Lewis F; Pentith J; Axon AT; Dixon MF; Quirke P Helicobacter; 1996 Dec; 1(4):219-26. PubMed ID: 9398872 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]